EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease

Jiawei Geng iD, Xixian Ruan, Xing Wu, Xuejie Chen, Tian Fu, Dipender Gill, Stephen Burgess, Jie Chen, Jonas F Ludvigsson, Susanna C Larsson iD, Xue Li, Zhongyan Du und 1 weitere

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Jiawei Geng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Blood-Stasis-Toxin Syndrome, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Mendelian Randomization Analysis, Genome-Wide Association Study, Gastrointestinal Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Swedish Research Council, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The molecular mechanisms underlying the association between type 2 diabetes (T2D) and gastrointestinal (GI) disease are unclear. To identify protein pathways, we conducted a two‐stage network Mendelian randomisation (MR) study. Materials and Methods Genetic instruments for T2D were obtained from a large‐scale summary‐level genome‐wide meta‐analysis. Genetic associations with blood protein levels were obtained from three genome‐wide association studies on plasma proteins (i.e. the deCODE study as the discovery and the UKB‐PPP and Fenland studies as the replication). Summary‐level data on 10 GI diseases were derived from genome‐wide meta‐analysis of the UK Biobank and FinnGen. MR and colocalisation analyses were performed. Pathways were constructed according to the directionality of total and indirect effects, and corresponding proportional mediation was estimated. Druggability assessments were conducted across four databases to prioritise protein mediators.

Results

Genetic liability to T2D was associated with 69 proteins in the discovery protein dataset after multiple testing corrections. All associations were replicated at the nominal significance level. Among T2D‐associated proteins, genetically predicted levels of nine proteins were associated with at least one of the GI diseases. Genetically predicted levels of SULT2A1 (odds ratio = 1.98, 95% CI 1.80–2.18), and ADH1B (odds ratio = 2.05, 95% CI 1.43–2.94) were associated with cholelithiasis and cirrhosis respectively. SULT2A1 and cholelithiasis (PH4 = 0.996) and ADH1B and cirrhosis (PH4 = 0.931) have strong colocalisation support, accounting for the mediation proportion of 72.8% (95% CI 45.7–99.9) and 42.9% (95% CI 15.5–70.4) respectively.

Conclusions

The study identified some proteins mediating T2D‐GI disease associations, which provided biological insights into the underlying pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Mendelian Randomization AnalysisGenome-Wide Association StudyGastrointestinal DiseasesGenetic Predisposition to DiseaseHumansSulfotransferasesAlcohol DehydrogenasePolymorphism, Single NucleotideBlood Proteins

Stichwörter der Autor:innen

Mendelian randomisationdrug targetgastrointestinal diseasesprotein biomarkertype 2 diabetes

Substanzen

ADH1B protein, humanSulfotransferasesAlcohol DehydrogenaseBlood Proteins

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Blood-Stasis-Toxin Syndrome, Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Big Data in Health Science School of Public Health, Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

ORCID-Profile: Jiawei Geng, Susanna C Larsson

Förderung

  • National Natural Science Foundation of China
  • Swedish Research Council
  • UK Research and Innovation Medical Research Council
  • Science Fund for Distinguished Young Scholars of Zhejiang Province
  • Medical Research Council
  • Wellcome Trust
  • Swedish Cancer Society
  • Swedish Heart Lung Foundation

Zitieren

APA

Geng, J., Ruan, X., Wu, X., Chen, X., Fu, T., Gill, D., Burgess, S., Chen, J., Ludvigsson, J. F., Larsson, S. C., Li, X., Du, Z., & Yuan, S. (2025). Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16087

Vancouver

Geng J, Ruan X, Wu X, Chen X, Fu T, Gill D, et al. Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16087

BibTeX
@article{Geng2025,
  author = {Geng, Jiawei and Ruan, Xixian and Wu, Xing and Chen, Xuejie and Fu, Tian and Gill, Dipender and Burgess, Stephen and Chen, Jie and Ludvigsson, Jonas F and Larsson, Susanna C and Li, Xue and Du, Zhongyan and Yuan, Shuai},
  title = {Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16087}
}
Kostenlos starten →